T1	Age 17 28	57-year-old
T2	Sex 29 34	woman
T3	Sign_symptom 69 73	mass
E1	Sign_symptom:T3 
T4	Lab_value 51 68	rapidly enlarging
R1	MODIFY Arg1:T4 Arg2:E1	
T5	Biological_structure 81 102	left side of her neck
R2	MODIFY Arg1:T5 Arg2:E1	
T6	Date 106 110	2010
E2	Date:T6 
T7	Therapeutic_procedure 134 147	thyroidectomy
E3	Therapeutic_procedure:T7 
T8	Detailed_description 128 133	total
R3	MODIFY Arg1:T8 Arg2:E3	
T9	Therapeutic_procedure 165 175	dissection
E4	Therapeutic_procedure:T9 
T10	Biological_structure 152 164	central neck
R4	MODIFY Arg1:T10 Arg2:E4	
T11	Distance 194 200	3.8-cm
T12	Disease_disorder 212 226	thyroid cancer
E5	Disease_disorder:T12 
T13	Detailed_description 201 211	anaplastic
R5	MODIFY Arg1:T13 Arg2:E5	
R6	MODIFY Arg1:T11 Arg2:E5	
T14	Disease_disorder 300 314	thyroid cancer
E6	Disease_disorder:T14 
T15	Detailed_description 278 299	poorly differentiated
R7	MODIFY Arg1:T15 Arg2:E6	
T16	Detailed_description 257 274	oncocytic variant
R8	MODIFY Arg1:T16 Arg2:E6	
T17	Sign_symptom 485 493	involved
E7	Sign_symptom:T17 
T18	Biological_structure 468 479	lymph nodes
T19	Lab_value 460 467	3 of 12
R9	MODIFY Arg1:T19 Arg2:T18	
R10	MODIFY Arg1:T18 Arg2:E7	
T20	Diagnostic_procedure 423 440	Resection margins
E8	Diagnostic_procedure:T20 
T21	Lab_value 446 454	positive
#1	AnnotatorNotes T21	positive for cancer cells, specifically
R11	MODIFY Arg1:T21 Arg2:E8	
T22	Date 498 511	3 weeks after
E9	Date:T22 
T23	Diagnostic_procedure 531 544	thyroglobulin
E10	Diagnostic_procedure:T23 
T24	Detailed_description 525 530	serum
R12	MODIFY Arg1:T24 Arg2:E10	
T25	Lab_value 555 577	17.2 ng per milliliter
R13	MODIFY Arg1:T25 Arg2:E10	
T26	Diagnostic_procedure 597 621	thyroglobulin antibodies
E11	Diagnostic_procedure:T26 
T27	Lab_value 584 596	undetectable
R14	MODIFY Arg1:T27 Arg2:E11	
T28	Therapeutic_procedure 655 672	radiation therapy
E12	Therapeutic_procedure:T28 
T29	Medication 684 695	carboplatin
E13	Medication:T29 
T30	Medication 700 710	paclitaxel
E14	Medication:T30 
T31	Medication 711 723	chemotherapy
E15	Medication:T31 
R15	SUB_PROCEDURE Arg1:E14 Arg2:E15	
R16	SUB_PROCEDURE Arg1:E13 Arg2:E15	
T32	Diagnostic_procedure 735 748	thyroglobulin
E16	Diagnostic_procedure:T32 
T33	Detailed_description 729 734	serum
R17	MODIFY Arg1:T33 Arg2:E16	
T34	Date 758 771	4 weeks after
E17	Date:T34 
T35	Lab_value 829 851	12.0 ng per milliliter
R18	MODIFY Arg1:T35 Arg2:E16	
T36	Diagnostic_procedure 863 868	scans
E18	Diagnostic_procedure:T36 
T37	Date 878 892	3 months later
E19	Date:T37 
T38	Sign_symptom 927 931	mass
E20	Sign_symptom:T38 
T39	Biological_structure 909 926	right-sided hilar
R19	MODIFY Arg1:T39 Arg2:E20	
T40	Medication 998 1008	everolimus
E21	Medication:T40 
T41	Dosage 1046 1057	10 mg daily
R20	MODIFY Arg1:T41 Arg2:E21	
T42	Date 1059 1074	Within 6 months
E22	Date:T42 
T43	Diagnostic_procedure 1086 1091	scans
E23	Diagnostic_procedure:T43 
T44	Clinical_event 1076 1085	follow-up
E24	Clinical_event:T44 
T45	Coreference 1108 1114	lesion
E25	Coreference:T45 
R21	IDENTICAL Arg1:E25 Arg2:E20	
T46	Sign_symptom 1127 1145	diminished in size
E26	Sign_symptom:T46 
R22	MODIFY Arg1:E25 Arg2:E26	
T47	Area 1152 1165	3.0 by 2.6 cm
T48	Area 1169 1182	1.1 by 0.8 cm
R23	MODIFY Arg1:T47 Arg2:E26	
R24	MODIFY Arg1:T48 Arg2:E26	
T49	Duration 1200 1209	18 months
E27	Duration:T49 
T50	Sign_symptom 1225 1233	response
E28	Sign_symptom:T50 
T51	Medication 1237 1247	everolimus
E29	Medication:T51 
T52	Diagnostic_procedure 1249 1254	scans
E30	Diagnostic_procedure:T52 
T53	Disease_disorder 1264 1283	progressive disease
E31	Disease_disorder:T53 
T54	Diagnostic_procedure 1318 1333	mediastinoscopy
E32	Diagnostic_procedure:T54 
T55	Therapeutic_procedure 1339 1346	removal
E33	Therapeutic_procedure:T55 
T56	Sign_symptom 1353 1361	enlarged
E34	Sign_symptom:T56 
T57	Biological_structure 1362 1372	lymph node
R25	MODIFY Arg1:T57 Arg2:E34	
R26	MODIFY Arg1:T57 Arg2:E33	
T58	Disease_disorder 1412 1426	thyroid cancer
E35	Disease_disorder:T58 
T59	Detailed_description 1401 1411	anaplastic
T60	Detailed_description 1390 1400	metastatic
R27	MODIFY Arg1:T60 Arg2:E35	
R28	MODIFY Arg1:T59 Arg2:E35	
T61	Diagnostic_procedure 1489 1499	sequencing
E36	Diagnostic_procedure:T61 
T62	Detailed_description 1477 1488	Whole-exome
R29	MODIFY Arg1:T62 Arg2:E36	
T63	Diagnostic_procedure 1517 1523	biopsy
E37	Diagnostic_procedure:T63 
T64	Detailed_description 1539 1572	pretreatment and resistant tumors
R30	MODIFY Arg1:T64 Arg2:E37	
T65	Detailed_description 1589 1601	blood sample
R31	MODIFY Arg1:T65 Arg2:E37	
*	OVERLAP E1 E2
R32	BEFORE Arg1:E2 Arg2:E3	
*	OVERLAP E3 E4 E5 E6
R33	BEFORE Arg1:E6 Arg2:E8	
*	OVERLAP E8 E7
R34	BEFORE Arg1:E7 Arg2:E9	
*	OVERLAP E9 E10 E11
R35	BEFORE Arg1:E11 Arg2:E12	
*	OVERLAP E12 E15
R36	BEFORE Arg1:E15 Arg2:E16	
*	OVERLAP E16 E17
R37	BEFORE Arg1:E17 Arg2:E18	
*	OVERLAP E18 E19 E20 E38 E21
T66	Clinical_event 980 994	clinical trial
E38	Clinical_event:T66 
T67	Detailed_description 972 979	phase 2
R38	MODIFY Arg1:T67 Arg2:E38	
R39	BEFORE Arg1:E21 Arg2:E22	
*	OVERLAP E22 E24 E23 E25 E26
R40	BEFORE Arg1:E26 Arg2:E27	
*	OVERLAP E27 E28 E29
R41	BEFORE Arg1:E29 Arg2:E30	
*	OVERLAP E30 E31 E32 E33 E34 E35 E36 E37
